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Gram-positive anaerobic cocci (GPAC) account for 24%e31% of the anaerobic bacteria isolated from
human clinical specimens. At present, GPAC are under-represented in the Biotyper MALDI-TOF MS
database. Proﬁles of new species have yet to be added. We present the optimization of the matrix-
assisted laser desorptioneionization time-of-ﬂight mass spectrometry (MALDI-TOF MS) database for
the identiﬁcation of GPAC. Main spectral proﬁles (MSPs) were created for 108 clinical GPAC isolates.
Identity was conﬁrmed using 16S rRNA gene sequencing. Species identiﬁcation was considered to be
reliable if the sequence similarity with its closest relative was 98.7%. The optimized database was
validated using 140 clinical isolates. The 16S rRNA sequencing identity was compared with the MALDI-
TOF MS result. MSPs were added from 17 species that were not yet represented in the MALDI-TOF MS
database or were under-represented (fewer than ﬁve MSPs). This resulted in an increase from 53.6% (75/
140) to 82.1% (115/140) of GPAC isolates that could be identiﬁed at the species level using MALDI-TOF MS.
An improved log score was obtained for 51.4% (72/140) of the strains. For strains with a sequence sim-
ilarity <98.7% with their closest relative (n ¼ 5) or with an inconclusive sequence identity (n ¼ 4), no
identiﬁcation was obtained by MALDI-TOF MS or in the latter case an identity with one of its relatives. For
some species the MSP of the type strain was not part of the conﬁned cluster of the corresponding clinical
isolates. Also, not all species formed a homogeneous cluster. It emphasizes the necessity of adding
sufﬁcient MSPs of human clinical isolates. A.C.M. Veloo, CMI 2016;22:793
© 2016 European Society of Clinical Microbiology and Infectious Diseases. Published by Elsevier Ltd.
All rights reserved.Introduction
The introduction of matrix-assisted laser desorptioneionization
time-of-ﬂight mass spectrometry (MALDI-TOF MS) for the identi-
ﬁcation of bacteria isolated from human specimens has led to a
revolution in medical diagnostic microbiology laboratories [1]. Thisin 1, 9713 GZ Groningen,
o).
biology and Infectious Diseases. Puis especially relevant for bacteria for which the identiﬁcation is
time consuming and technically challenging. Identiﬁcation of
anaerobic bacteria by MALDI-TOF MS results in faster and more
reliable results [2e4]. The two main groups of anaerobic bacteria
encountered in human infections are the Bacteroides fragilis group
(43%) and Gram-positive anaerobic cocci (GPAC, 24%e31%) [5,6].
The performance of MALDI-TOF MS for the identiﬁcation of
B. fragilis group species has already been validated with 94%e98%
identiﬁed to the species level [7,8]. The validation of MALDI-TOFMS
for the identiﬁcation of GPAC has been limited until now, except for
the most prevalent GPAC species (Finegoldia magna, Parvimonasblished by Elsevier Ltd. All rights reserved.
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represented in the MALDI-TOF MS database and proﬁles of new
species have yet to be added. Previous studies have shown that the
addition of reference spectra of clinical isolates of anaerobic bac-
teria results in an increase in the number of correct identiﬁcations
[9,10]. In this study we present the optimization of the Biotyper
MALDI-TOF MS database for the identiﬁcation of GPAC by including
main spectral proﬁles (MSP) of 16S rRNA sequenced clinical iso-
lates. The primary goals were to have at least ﬁve MSPs [11] present
in the database for each species and also the addition of MSPs of
species not yet represented in the Biotyper MALDI-TOF MS
database.Material and methods
Bacterial strains
A selection of 108 clinical isolates of GPAC, including six type
strains, were collected by laboratories associated with the Euro-
pean Network for the Rapid Identiﬁcation of Anaerobes (ENRIA)
and sent to the University Medical Centre, Groningen (Table 1).
Upon arrival strains were cultured on Brucella Blood Agar
(Mediaproducts, Groningen, the Netherlands) supplemented withTable 1
An overview of main spectral proﬁles (MSPs) of Gram-positive anaerobic cocci
(GPAC) species already present in the MALDI-TOF MS database and of MSPs added to
the database
Species No. of MSPs
Present Added Total
Peptostreptococcus stomatis 0 5 5
Peptostreptococcus anaerobius 4 3 7
Peptostreptococcus canis 0 2 2
Peptococcus niger 1 5 6
Finegoldia magna 11 0 11
Murdochiella asaccharolytica 0 3 3
Parvimonas micra 7 0 7
Anaerococcus murdochii 1 8 9
Anaerococcus degenerii a 0 2b 2
Anaerococcus lactolyticus 1 4 5
Anaerococcus tetradius 2 4 6
Anaerococcus prevotii 2 2 4
Anaerococcus vaginalis 1 12 13
Anaerococcus hydrogenalis 3 0 3
Anaerococcus senegalensis a 0 1 1
Anaerococcus obesiensis a 0 1 1
Anaerococcus octavius 2 0 2
Anaerococcus provenciensis a 0 2 2
Anaerococcus nagyae a 0 3b 3
Peptoniphilus grossensis a 0 6 6
Peptoniphilus tyrelliae 0 1b 1
Peptoniphilus rhinitidis a 0 3 3
Peptoniphilus harei 4 7 11
Peptoniphilus gorbachii 1 5 6
Peptoniphilus timonensis a 0 1 1
Peptoniphilus olsenii 0 4b 4
Peptoniphilus lacrimalis 0 5 5
Peptoniphilus koenoeneniae 0 2b 2
Peptoniphilus duerdenii 0 6b 6
Peptoniphilus indolicus 2 0 2
Peptoniphilus asaccharolyticus 1 0 1
Peptoniphilus ivorii 1 3 4
Peptoniphilus coxii 0 8 8
GPAC, Gram-positive anaerobic cocci; MALDI-TOF, matrix-assisted laser desorp-
tioneionization time-of-ﬂight mass spectrometry; MSP, main spectral proﬁles.
a These species are not validly published.
b The type strains of these species were also included; Anaerococcus degenerii
DSM29674, Anaerococcus nagyae DSM101193, Peptoniphilus tyrelliae CCUG59621,
Peptoniphilus olsenii CCUG53342, Peptoniphilus koenoeneniae CCUG56067 and Pep-
toniphilus duerdenii CCUG56065.haemin and vitamin K1 and incubated at 37C in an anaerobic at-
mosphere (80% N2, 10% CO2, 10% H2) for 48 h. After repeated sub-
culturing on Brucella Blood Agar, strains were stored on
microbank™ beads (Pro-Lab Diagnostics, Bromborough, UK)
at 80C and ethanol suspensions were made as described previ-
ously [12], which were stored at 20C until use.
Identiﬁcation using 16S rRNA sequencing
All strains were identiﬁed with 16S rRNA gene sequencing. DNA
of the strains was isolated as described previously [13]. The PCR
was performed using universal primers targeting the 16S rRNA
gene [14]. The identity of the strains was determined by comparing
either the sequence obtained with the forward primer and/or
reverse primer or in the case of consensus the complete sequence
of the 16S rRNA gene with sequences available in GenBank (http://
www.ncbi.nlm.nih.gov/genbank/) using BLASTn (https://blast.ncbi.
nlm.nih.gov). Identiﬁcation at the species level was considered
reliable if the sequence similarity between the unknown strain and
its closest relative was 98.7% [15]. Only strains that could be
identiﬁed at the species level were included in the MALDI-TOF MS
database.
Identiﬁcation using MALDI-TOF MS
Strains were identiﬁed using MALDI-TOF MS as described pre-
viously [12]. Brieﬂy, after 48 h of incubation, fresh colonies were
spotted twice on to a stainless steel target using a toothpick. One
spot was overlaid with 1 mL HCCA matrix (a-cyano-4-hydroxycin-
namic acid in 50% acetonitrile/2.5% triﬂuoroacetic acid) and left to
dry at ambient temperature. An on-target extraction was per-
formed on the second spot by overlaying the bacteria with 1 mL 70%
formic acid. After drying at ambient temperature the spot was
immediately covered with 1 mL HCCA matrix. Measurements were
performed using the Microﬂex (Bruker Daltonik GmbH, Bremen,
Germany). Spectra were obtained by summing shot steps of 40,
with a minimum laser power of 30% and amaximum laser power of
40%, until 240 satisfactory shots were obtained.
Main spectral proﬁles
A full extraction was performed on the bacterial ethanol sus-
pensions as described previously [12]. Brieﬂy, the suspension was
centrifuged at 13 000 g for 2 min and the supernatant was dis-
regarded. The centrifugation step was repeated and the remaining
supernatant was carefully removed by pipetting. The pellet was
resuspended in 30 mL 70% formic acid and an equal volume of
acetonitrile. After centrifugation at 13,000 g for 2 min, 1 mL of the
supernatant was spotted on the stainless steel target 12 times.
Immediately after drying at ambient temperature, 1 mL HCCA ma-
trix was added to the spot and left to dry at ambient temperature.
From each spot, three spectra were obtained using the Microﬂex.
Before each measurement, the MALDI-TOF MS system was cali-
brated using a bacterial test standard (Bruker Daltonik). For each
spectrum, 240 satisfactory shots were summed in shot steps of 40,
with a minimum laser power of 30% and amaximum laser power of
40%.
Obtained spectra were manually evaluated in FLEXANALYSIS
3.3.80.0. For each spectrum the appropriate method was chosen,
MBT_standard, smoothing and baseline subtraction were per-
formed. The set of spectra derived from one strainwere checked for
peak shifts, which should not exceed 500 ppm (the peak shift
should not exceed 2 Da for a peak at 4000 Da). Flat liners, outliers
and spectra that differ remarkably from the rest were removed
from the data set. An MSP from the remaining spectra, comprising
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Dendrograms of the created MSPs and the MSPs already present in
the MALDI-TOF MS database were calculated in BIOTYPER 3.0.
Validation
The performance of the optimized database was validated using
a total of 140 clinical isolates of GPAC, which were consecutively
isolated from a variety of human clinical specimens. To evaluate
also the MSPs of species less commonly encountered in clinical
specimens, a minority of the strains (n ¼ 11) were from a different
period. The identity of strains was established using 16S rRNA gene
sequencing as described above and compared with the identity
obtained using MALDI-TOF MS.
Only strains belonging to the genera mostly encountered in
human infectionsdPeptoniphilus, Anaerococcus, Peptostreptococcus,
Parvimonas, Finegoldia, Peptococcus and Murdochielladwere used.
Spectra obtained were compared with the current Bruker database
(db5627) and with the optimized Bruker database augmented with
GPAC MSPs of the ENRIA strains. Obtained log scores were inter-
preted as recommended by the manufacturer. Log scores 2 as a
high conﬁdence identiﬁcation, log score >1.7 and <2 as a low
conﬁdence identiﬁcation and log score 1.7 as no reliable
identiﬁcation.
Results
Optimization of the MALDI-TOF MS database
MSPs of strains that were not represented by ﬁve or more pro-
ﬁles and MSPs of species that were not present in the Bruker
database were created and added (Table 1). The obtained dendro-
grams are shown in Figs. 1 and 2. The species in the genera405006007008009001000
Fig. 1. Dendrogram of main spectral proﬁles created of strains bPeptococcus, Murdochiella and Peptostreptococcus each form a
conﬁned cluster, without obvious intra-species variation. For some
species of the genus Anaerococcus intra-species variation is
observed. This phenomenon was observed for Anaerococcus mur-
dochii, Anaerococcus lactolyticus, Anaerococcus prevotii and Anae-
rococcus tetradius. The MSPs of the type strains of Anaerococcus
vaginalis, Anaerococcus lactolyticus and P. harei, which were already
present in the Bruker database, are not part of the conﬁned cluster
of MSPs of the clinical isolates of these three species. This phe-
nomenon was not observed for all species of which MSPs were
added to the database.Validation
The results of the validation of the optimized database are
summarized in Table 2. The MSPs of P. micra and F. magnawere not
added since these species were already represented in the current
database with ﬁve or more proﬁles. One F. magna strain repeatedly
failed to produce any peaks. Peptostreptococcus stomatis, Murdo-
chiella asaccharolytica, Peptoniphilus lacrimalis, Peptoniphilus gor-
bachii, Peptoniphilus grossensis, Peptoniphilus duerdenii,
Peptoniphilus olsenii, Peptoniphilus coxii, A. vaginalis and Anaero-
coccus senegalensis all provided useful MSPs and clinical isolates
could be identiﬁedwith high conﬁdence. Even though oneMSPwas
added of Anaerococcus obesiensis, this species could not be identi-
ﬁed using the optimized database. Anaerococcus hydrogenalis could
only be identiﬁed with low conﬁdence, even though three MSPs
were already present in the database. In general, the log score of
clinical isolates belonging to species of which MSPs were added
increased. This was especially observed within the species P. harei,
A. vaginalis, Peptostreptococcus anaerobius, Peptoniphilus ivorii,
A. lactolyticus and A. tetradius. After optimization of the Bruker
database, the proportion of species identiﬁed with high conﬁdence01002003000
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Peptostreptococcus stomatis ENR0038
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Peptostreptococcus anaerobius HU28371_2 PN
Peptostreptococcus anaerobius HU33518_2 PN
Peptostreptococcus anaerobius ENR0004
Peptostreptococcus anaerobius ENR0005
Peptostreptococcus anaerobius ENR0006
Peptostreptococcus anaerobius DSM 2949T DS
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Peptoniphilus indolicus DSM 20464T DSM
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Peptoniphilus harei ENR0423
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Peptoniphilus olsenii CCUG 53342T
Peptoniphilus olsenii ENR0449 2016
Peptoniphilus olsenii ENR0510 2016
Peptoniphilus olsenii ENR0511 2016
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Peptoniphilus indolicus
Peptoniphilus asaccharolyƟcus
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elonging to the genera Peptoniphilus and Peptostreptococcus.
01002003004005006007008009001000
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Anaerococcus vaginalis ENR0022
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Anaerococcus hydrogenalis DSM 7454T DSM
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Anaerococcus prevotii ENR0535
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Anaerococcus nagyiae ENR0652
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Anaerococcus provenciensis ENR0667n
Anaerococcus provenciensis ENR0675  nieu
Parvimonas micra CCM 3776 CCM
Parvimonas micra P10bue_li10AN USH
Parvimonas micra P10flue_li2AN USH
Parvimonas micra P10bue_li2AN USH
Parvimonas micra P10bue_li5AN USH
Parvimonas micra P6flue_re1AN USH
Parvimonas micra DSM 20468T DSM
Finegoldia magna 06_469 IBS
Finegoldia magna 07_937 N5 IBS
Finegoldia magna DSM 20369 DSM
Finegoldia magna DSM 20362 DSM
Finegoldia magna HU29642_2 PNU
Finegoldia magna DSM 20470T DSM
Finegoldia magna HU29644_1 PNU
Finegoldia magna HU27914 PNU
Finegoldia magna HU30296_1 PNU
Finegoldia magna 110706_D1 LUMC
Finegoldia magna DSM 20472 DSM
Anaerococcus degenerii ENR0615
Anaerococcus gpac104 ENR0041
Anaerococcus murdochii ENR0013 nieuw
Anaerococcus murdochii ENR0015
Anaerococcus murdochii ENR0622
Anaerococcus murdochii ENR0014x
Anaerococcus murdochii ENR0025
Anaerococcus murdochii ENR0134n
Anaerococcus murdochii DSM 21462T DSM
Anaerococcus murdochii ENR0011
Anaerococcus murdochii ENR0012
Anaerococcus lactolyticus DSM 7456T DSM
Anaerococcus lactolyticus ENR0010x
Anaerococcus lactolyticus ENR0440
Anaerococcus lactolyticus ENR0480
Anaerococcus lactolyticus ENR0475
Anaerococcus tetradius 123 RLT
Anaerococcus tetradius ENR0017n
Anaerococcus tetradius DSM 2951T DSM
Anaerococcus tetradius ENR0326
Anaerococcus tetradius ENR0016
Anaerococcus tetradius ENR0441
Murdochia asaccharolytica ENR0024
Murdochiella asaccharolytica 0064
Murdochiella asaccharolytica 0066
Murdochiella asaccharolyƟca
Anaerococcus tetradius
Anaerococcus lactolyƟcus
Anaerococcus murdochii
Anaerococcus degenerii
Finegoldia magna
Parvimonas micra
Anaerococcus provenciensis
Anaerococcus octavius
Anaerococcus nagyae
Peptococcus niger
Anaerococcus prevoƟi
Anaerococcus hydrogenalis
Anaerococcus obesiensis
Anaerococcus s negalensis
Anaerococcus vaginalis
Fig. 2. Dendrogram of main spectral proﬁles created of strains belonging to the genera Anaerococcus, Murdochiella, Peptococcus, Finegoldia and Parvimonas.
Table 2
MALDI-TOF MS identiﬁcation results of GPAC clinical isolates (n ¼ 140) compared with the Bruker database and with the Bruker database supplemented with MSPs of well-
characterized GPAC species
Species ID Bruker database Bruker database þ ENRIA GPAC database
Score 2 Score >1.7 to <2 Score 1.7 Score 2 Score >1.7 to <2 Score 1.7 No. of strains of which the
log score increased
Peptoniphilus harei (n ¼ 28) 19 8 1 28 0 0 26
Finegoldia magna (n ¼ 25)a 16 8 1 16 8 1 0
Parvimonas micra (n ¼ 27)a 25 2 0 25 2 0 0
Anaerococcus vaginalis (n ¼ 8) 0 2 6 8 0 0 8
Anaerococcus murdochii (n ¼ 5) 4 1e 0 5 0 0 1
Anaerococcus hydrogenalis (n ¼ 2) 0 0 2 0 2e 0 2
Anaerococcus obesiensis (n ¼ 2)b 0 0 2 0 0 2 0
Peptostreptococcus anaerobius (n ¼ 8) 7 1 0 8 0 0 8
Peptostreptococcus stomatis (n ¼ 2)b 0 0 2 1 1 0 2
Murdochiella asaccharolytica (n ¼ 3)b 0 0 3 3 0 0 3
Peptoniphilus coxii (n ¼ 6)b 0 0 6 5 1 0 6
Peptoniphilus lacrimalis (n ¼ 3)b 0 0 3 3 0 0 3
Peptoniphilus grossensis (n ¼ 2) b 0 1 1 1 1 0 2
Peptoniphilus lactolyticus (n ¼ 2) 1 0 1 2 0 0 1
Peptoniphilus gorbachii (n ¼ 2)b 1 0 1 2 0 0 2
Peptoniphilus duerdenii (n ¼ 2)b 0 0 2 2 0 0 2
Different GPAC species (n ¼ 4)c 0 0 4 4 0 0 4
GPAC (n ¼ 9)d 2 0 7 2 1 6 2
Total (n) 75 23 42 115 16 9 72
% of all strains 53.6% 16.4% 30.0% 82.1% 11.4% 6.4% 51.4%
GPAC, Gram-positive anaerobic cocci; MALDI-TOF MS, matrix-assisted laser desorptioneionization time-of-ﬂight mass spectrometry; MSP, main spectral proﬁle.
a No additional reference spectra were added to the MALDI-TOF MS database.
b Species was not present in the MALDI-TOF MS database.
c This group consisted of Peptoniphilus olsenii, Anaerococcus senegalensis, Anaerococcus degenerii and Anaerococcus tetradius. Species indicated in bold were already
represented in the original Bruker database.
d Strains could not be identiﬁed at the species level using 16S rRNA gene sequencing. It contains possible new species and strains of which the sequence could not
differentiate between two species. Two strains identiﬁed by sequencing as Anaerococcus murdochii/degenerii and Anaerococcus vaginalis/obesiensiswere identiﬁed by MALDI-
TOF MS as Anaerococcus murdochii (log score >2) and Anaerococcus vaginalis (log score >2), respectively.
e The obtained log score indicated the correct genus, but the wrong species name.
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the number of strains that could not be identiﬁed (log score <1.7)
decreased from 30.0% (42/140) to 6.4% (9/140). Almost half of the
strains (51.4%, 72/140) yielded a higher log score.
Nine clinical isolates could not be identiﬁed by 16S rRNA gene
sequencing. This was either because the sequence similarity with
two different close relatives was highly similar. Therefore, no dif-
ferentiation could be made between the two species. This was the
case for four strains of which for two a MALDI-TOF MS identiﬁca-
tion was obtained with a log score 2 with one of its closest rela-
tives. Five strains yielded a sequence similarity <98.7% with their
closest relative and could not be identiﬁed using MALDI-TOF MS.
These strains may represent new species.
Discussion
The aim of the ENRIA project is to optimize and validate the
BiotyperMALDI-TOFMS database for the identiﬁcation of anaerobic
bacteria. The GPAC are a clinically important group of anaerobic
bacteria comprising several genera. They are a phylogenetically
heterogeneous group of organisms [16]. TheMALDI-TOFMS spectra
used for identiﬁcation represent the mass range of 2e20 kDa and
consist predominantly of ribosomal and housekeeping proteins
that have taxonomic relevance [17]. The heterogeneity encountered
in phylogenetic analyses based on 16S rRNA is therefore also ex-
pected while creating MSPs for database optimization.
It was observed that certain species in the genus Anaerococcus
do not form a conﬁned cluster. Also multiple clusters are observed
for the species A. murdochii and A. lactolyticus. Phylogenetic ana-
lyses showed that Anaerococcus degenerii is closely related to
A. murdochii and A. lactolyticus [18]. F. magna tends to give log
scores <2, probably because it possesses a very hard cell wall that
hampers the release of proteins. As it is the only species present in
the genus Finegoldia, accepting a log score >1.8 for high conﬁdence
identiﬁcation is justiﬁed.
For some GPAC species the type strain yielded a different MSP
compared with the clinical isolates of that species. This was also
observed for P. harei in a previous study by Veloo et al. [9], in which
a different MALDI-TOF MS system and database were optimized for
the identiﬁcation of GPAC. In the present study this observationwas
conﬁrmed for this and other species. This emphasizes the necessity
of adding new MSPs of well-characterized clinical isolates to the
database of the MALDI-TOF MS system. The fact that A. obesiensis
and A. hydrogenalis cannot be identiﬁed even though one and two
MSPs are present, demonstrates the necessity to have sufﬁcient
MSPs present in the database. Due to the addition of GPAC MSPs of
108 clinical isolates, the rate of reliable species identiﬁcation
increased from 53.6% (75/140) to 82.1% (115/140). For 51.4% (72/
140) of the tested strains a higher log score was obtained after
addition of the new MSPs. This is, in part, due to the fact that MSPs
of 17 species that were not yet represented in the database were
added, and partly due to the addition of MSPs of species that were
under-represented in the database. In the optimized database, 33
GPAC species are represented, of which 18 species are still under-
represented (fewer than ﬁve MSPs) [11].
Four strains with a 16S rRNA sequence similarity insufﬁcient to
differentiate between species were either identiﬁed as one of its
closest relatives or could not be identiﬁed at all. For example, one
strain had similar sequence similarities with A. vaginalis and
A. obesiensis and was identiﬁed with MALDI-TOF MS as A. vaginalis.
Five strains with a sequence similarity <98.7% could not be iden-
tiﬁed at all. Three of these unidentiﬁed strains had similar sequence
results (data not shown) and may represent a new species. One
strain has just been described as being a new species, Anaerococcus
nagyae [19].We conclude that the addition of further new MSPs of well-
characterized clinical isolates, permits more GPAC isolates
encountered in a medical microbiology laboratory to be identiﬁed
to species level. This seems especially valuable for species with a
high intra-species variation. The addition of species that were not
present in the database enhances the ability of MALDI-TOF MS to
comprehensively identify a broader range of clinical isolates, which
may allow us to better clarify their clinical relevance.
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